DHR 233.1 (+0.98%)
US2358511028Medical Diagnostics & ResearchDiagnostics & Research

Danaher (DHR) Stock Highlights

233.1 | +0.98%
2024-11-20 23:09:25
In 1984, Danahers founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GEs Biopharma business, now called Cytiva, which added to its life sciences segment.

Statistics

Range Today
228.89 233.73
Volume Today 2.66M
Range 1 Year
207.63 281.7
Volume 1 Year 696.97M
Range 3 Year
182.09 294.05
Volume 3 Year 2.24B
Range 10 Year
54.61 296.06
Volume 10 Year 8.8B

Highlights

Market Capitalization 166.48B (large)
Floating Shares 641.84M
Current Price 233.1
Price To Earnings 44.64
Price To Revenue 7.96
Price To Book 3.25
Earnings Per Share 5.29
Dividend Yield 0.45%
Dividend Per Share 1.08
Payout Ratio 24.91%

Performance

Latest +0.98%
1 Month -14.65%
3 Months -14.25%
6 Months -12.25%
1 Year +11.55%
3 Years -16.22%
5 Years +83.77%
10 Years +323.28%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.